AnaptysBio
ANAB
ANAB
114 hedge funds and large institutions have $831M invested in AnaptysBio in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 38 increasing their positions, 36 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8% less funds holding
Funds holding: 124 → 114 (-10)
48% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 21
Holders
114
Holding in Top 10
2
Calls
$6.23M
Puts
$17K
Top Buyers
| 1 | +$42.7M | |
| 2 | +$17.7M | |
| 3 | +$7.63M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$4.83M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$3.81M |
Top Sellers
| 1 | -$14.8M | |
| 2 | -$9.2M | |
| 3 | -$7.97M | |
| 4 |
EP
Eversept Partners
New York
|
-$3.71M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$1.82M |